Alcyone Therapeutics
Bonnie Szarzynski McIsaac has a diverse work experience spanning from 2004 to 2021. In 2004, they worked as an ACCOUNTEMPS for Robert Half International. From 2005 to 2011, they worked as an Accounts Payable Specialist for ANIKA THERAPEUTICS, INC, a Staff Accountant/Benefits Administrator for Design Partnership of Cambridge, an Assistant Controller for ARAMARK Conference Centers, a Staff Accountant for Margulies Perruzzi Architects, a Contractor - Accounting for Capsule Technologie, and a Staff Accountant for a Contractor. From 2015 to 2019, they worked as an Administration and Accounting for Haselmeier. Finally, in 2021, they took on the role of Senior Staff Accountant for Alcyone Therapeutics Inc. and President Of The Board Of Directors for THE LOWELL PHILHARMONIC ORCHESTRA LTD.
Bonnie Szarzynski McIsaac received their High School Diploma from Naugatuck High School in 1975. Bonnie then attended Regis College, graduating in 1979 with a BA in French/Economics. In 2005, they earned a MS in Training & Development from Lesley University.
Alcyone Therapeutics
Alcyone Therapeutics is a biotechnology company pioneering next-generation precision central nervous system (CNS) therapies to improve the lives of patients and families impacted by severe neurological conditions. Alcyone Therapeutics is advancing a pipeline of adeno-associated virus (AAV) gene therapy programs that leverage its proprietary, next-generation CNS delivery technology platform. Alcyone Therapeutics’ lead programs target the treatment of Rett syndrome and spinal muscular atrophy with respiratory distress type 1 (SMARD1).